Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Oncogene|October 1, 1990
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study GroupI Chiba, T Takahashi, M M Nau, et al.Cell Death and Differentiation|February 7, 2004
N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell linesM Cuello, A O Coats, I Darko, et al.The Journal of Clinical Investigation|June 1, 1987
myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and courseB E Johnson, D C Ihde, R W Makuch, et al.Cancer Research|November 15, 1991
Mutations in the p53 gene in primary human breast cancersR J Osborne, G R Merlo, T Mitsudomi, et al.Science (New York, N.Y.)|October 27, 1989
p53: a frequent target for genetic abnormalities in lung cancerT Takahashi, M M Nau, I Chiba, et al.Cancer Research|April 15, 1992
Frequency and diversity of p53 mutations in childhood rhabdomyosarcomaC A Felix, C C Kappel, T Mitsudomi, et al.Anticancer Research|March 1, 1995
Molecular genetic characterization of neuroendocrine lung cancer cell linesS L Lai, H Brauch, T Knutsen, et al.Oncogene|April 1, 1992
Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutationS M Bodner, J D Minna, S M Jensen, et al.Oncogene|January 1, 1992
p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical featuresT Mitsudomi, S M Steinberg, M M Nau, et al.Oncogene|May 1, 1993
A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasmC A Felix, E A Strauss, D D'Amico, et al.Pageof 4